Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-01-08 @ 4:58 AM
Study NCT ID:
NCT00651833
Status:
COMPLETED
Last Update Posted:
2024-09-03
First Post:
2008-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Sponsor:
Taiho Oncology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TPU-S1202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Fabio Benedetti, M.D., Chief Medical Officer
Old Organization:
Taiho Pharma USA, Inc.